GLASSIA Safety, Immunogenicity, and Bronchoalveolar Lavage Study
NCT02525861
·
clinicaltrials.gov ↗
PHASE3
Phase
COMPLETED
Status
34
Enrollment
INDUSTRY
Sponsor class
Conditions
Alpha1-antitrypsin Deficiency
Interventions
BIOLOGICAL:
GLASSIA
Sponsor
Baxalta now part of Shire